实用癌症杂志
實用癌癥雜誌
실용암증잡지
THE PRACTICAL JOURNAL OF CANCER
2015年
1期
136-138
,共3页
香菇多糖注射液%晚期结肠癌%FOLFOX方案化疗%免疫功能
香菇多糖註射液%晚期結腸癌%FOLFOX方案化療%免疫功能
향고다당주사액%만기결장암%FOLFOX방안화료%면역공능
Lentinan injection%Advanced colorectal cancer%FOLFOX chemotherapy%Immunologic function
目的:探讨香菇多糖注射液联合FOLFOX方案治疗晚期结肠癌的临床疗效。方法将90例晚期结肠癌患者按照住院时间先后顺序分组为对照组和治疗组。对照组:采用亚叶酸钙,200 mg/m2,静脉滴入,1次/天;奥沙利铂,100 mg/m2,静脉滴入,1次/天;5-氟尿嘧啶,400 mg/m2,静脉滴注,1次/天;5-氟尿嘧啶,600 mg/m2,持续静脉泵入22 h, d1-2。治疗组:在对照组治疗基础上,同时给患者采用香菇多糖注射液1 mg,2次/周,静脉滴注。观察2组患者的近、远期疗效和不良反应及对细胞因子的影响。结果治疗后,治疗组1、2、3年生存率分别为75.56%(34/45)、55.56%(25/45)、37.78%(17/45),与对照组71.11%(32/45)、35.56%(16/45)、24.44%(11/45)比较,1年生存率差异无统计学意义(P>0.05),2、3年生存率差异有统计学意义(P<0.05)。此外,2组患者近期临床疗效和不良反应比较,P均<0.05。2组患者治疗后血清IL-2和TNF-α及IFN-γ水平与治疗前比较,均出现明显上升,但治疗组升高较为显著( P<0.05)。结论相比FOLFOX方案化疗来说,采用香菇多糖注射液联合FOLFOX方案治疗晚期结肠癌,能提高患者近、远期疗效,且不良反应少,同时还能有效改善患者免疫功能,提高患者抵抗力。
目的:探討香菇多糖註射液聯閤FOLFOX方案治療晚期結腸癌的臨床療效。方法將90例晚期結腸癌患者按照住院時間先後順序分組為對照組和治療組。對照組:採用亞葉痠鈣,200 mg/m2,靜脈滴入,1次/天;奧沙利鉑,100 mg/m2,靜脈滴入,1次/天;5-氟尿嘧啶,400 mg/m2,靜脈滴註,1次/天;5-氟尿嘧啶,600 mg/m2,持續靜脈泵入22 h, d1-2。治療組:在對照組治療基礎上,同時給患者採用香菇多糖註射液1 mg,2次/週,靜脈滴註。觀察2組患者的近、遠期療效和不良反應及對細胞因子的影響。結果治療後,治療組1、2、3年生存率分彆為75.56%(34/45)、55.56%(25/45)、37.78%(17/45),與對照組71.11%(32/45)、35.56%(16/45)、24.44%(11/45)比較,1年生存率差異無統計學意義(P>0.05),2、3年生存率差異有統計學意義(P<0.05)。此外,2組患者近期臨床療效和不良反應比較,P均<0.05。2組患者治療後血清IL-2和TNF-α及IFN-γ水平與治療前比較,均齣現明顯上升,但治療組升高較為顯著( P<0.05)。結論相比FOLFOX方案化療來說,採用香菇多糖註射液聯閤FOLFOX方案治療晚期結腸癌,能提高患者近、遠期療效,且不良反應少,同時還能有效改善患者免疫功能,提高患者牴抗力。
목적:탐토향고다당주사액연합FOLFOX방안치료만기결장암적림상료효。방법장90례만기결장암환자안조주원시간선후순서분조위대조조화치료조。대조조:채용아협산개,200 mg/m2,정맥적입,1차/천;오사리박,100 mg/m2,정맥적입,1차/천;5-불뇨밀정,400 mg/m2,정맥적주,1차/천;5-불뇨밀정,600 mg/m2,지속정맥빙입22 h, d1-2。치료조:재대조조치료기출상,동시급환자채용향고다당주사액1 mg,2차/주,정맥적주。관찰2조환자적근、원기료효화불량반응급대세포인자적영향。결과치료후,치료조1、2、3년생존솔분별위75.56%(34/45)、55.56%(25/45)、37.78%(17/45),여대조조71.11%(32/45)、35.56%(16/45)、24.44%(11/45)비교,1년생존솔차이무통계학의의(P>0.05),2、3년생존솔차이유통계학의의(P<0.05)。차외,2조환자근기림상료효화불량반응비교,P균<0.05。2조환자치료후혈청IL-2화TNF-α급IFN-γ수평여치료전비교,균출현명현상승,단치료조승고교위현저( P<0.05)。결론상비FOLFOX방안화료래설,채용향고다당주사액연합FOLFOX방안치료만기결장암,능제고환자근、원기료효,차불량반응소,동시환능유효개선환자면역공능,제고환자저항력。
Objective To explore the clinical curative effect of lentinan injection combined FOLFOX for advanced color-ectal cancer.Methods 90 cases of patients with advanced colon cancer were divided into the control group and the treatment group.Control group received calcium leucovorin, 200 mg/m2 , intravenous drip, once/d;Oxaliplatin, 100 mg/m2 , intravenous drip,once/d;5-fluorouracil,400 mg/m2 ,the intravenous drip,once/d;5-fluorouracil,600 mg/m2 ,continuous intravenous pumping 22 h and d1-2.Treatment group received additional lentinan injection 1 mg,twice/week,intravenous drip on the basis of the con-trol treatment.The short-term and long-term curative effects,adverse reaction and the influence of cytokines of the 2 groups were observed.Results After treatment,1-,2-,3-year survival rates of the treatment group were 75.56% (34/45),55.56% (25/45),37.78%(17/45),and those of the control group were 71.11%(32/45),35.56%(16/45),24.44%(11/45),there was no statistically significant difference in 1-year survival rate (P>0.05),2-,3-year survival rate had statistically significant differ-ence (P<0.05).In addition,recent clinical curative effect and adverse reactions of the 2 groups had statistically significant difference,P<0.05.Serum IL-2,TNF alpha and IFN-gamma levels of the 2 groups after treatment had statistically significant difference,and treatment group had higher increase (P<0.05).Conclusion Compared with FOLFOX schemes,lentinan injec-tion combined with FOLFOX regimen for advanced colon cancer can improve short-term and long-term curative effects,with less adverse reactions,and it can effectively improve the patients'immune function and resistance.